Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.
| Last: | $0.2479 |
|---|---|
| Change Percent: | -20.21% |
| Open: | $0.298 |
| Close: | $0.2479 |
| High: | $0.3055 |
| Low: | $0.2396 |
| Volume: | 2,111,237 |
| Last Trade Date Time: | 10/22/2024 03:00:00 am |
| Market Cap: | $97 |
|---|---|
| Float: | 5,621,826 |
| Insiders Ownership: | N/A |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.notablelabs.com |
| Country: | IL |
| City: | Foster City |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Notable Labs Ltd. (NASDAQ: NTBL).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
